Official UK procurement notice
NP35418 Contrast Media Agents
Authority: The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS") (NHS & healthcare)
What is being bought8 lots · detail below
Published requirement descriptionThe framework agreement is for the supply of Contrast Media Agents to NHS Scotland and the Health and Social Care (HSC) Trusts in Northern Ireland.
The Goods have been split into eight (8) categories, each of which is identified as a “Lot”. Full details of each Lot is contained in section II.2 of this notice.
CPV: Diagnostic agents · Pharmaceutical products · Reagents and contrast media · X-ray contrast media
Lots and requirements (8)Procurement structure
8 lots · no lot values publishedLot #1Barium Based Contrast Agents
Supply of barium based contrast agents to NHS Scotland and the Health and Social Care Trusts in Northern Ireland.
Lot 1 - a single supplier framework agreement awarded on a line by line basis.
Lot #2Ultrasound Contrast Agents
Supply of ultrasound contrast agents to NHS Scotland and the Health and Social Care Trusts in Northern Ireland.
Lot 2 - a single supplier framework agreement awarded on a line by line basis.
Lot #3Macrocyclic Gadolinium Based Contrast Agents
Supply of macrocyclic gadolinium based contrast agents to NHS Scotland and the Health and Social Care Trusts in Northern Ireland.
Lot 3 - as an unranked multi-supplier framework agreement awarded on a line by line basis.
Lot #4Linear Gadolinium Based Contrast Agents
Supply of linear gadolinium based contrast agents to NHS Scotland and the Health and Social Care Trusts in Northern Ireland.
Lot 4 - a single supplier framework agreement awarded on a line by line basis.
Lot #5Non-ionic monomeric iodine-based contrast agents
Supply of non-ionic monomeric iodine based contrast agents to NHS Scotland and the Health and Social Care Trusts in Northern Ireland.
Lot 5 - an unranked multi-supplier framework agreement awarded on line by line basis.
Lot #6Non-ionic dimeric Iodine based contrast agents
Supply of non-ionic dimeric iodine based contrast agents to NHS Scotland and the Health and Social Care Trusts in Northern Ireland.
Lot 6 - a single supplier framework agreement awarded on a line by line basis.
Lot #7Non-ionic monomer Iomeprol contrast agent
Supply of non-ionic monomer iomeprol contrast agents to NHS Scotland and the Health and Social Care Trusts in Northern Ireland.
Lot 7 - a single supplier framework agreement awarded on a line by line basis.
Lot #8Additional Iodine based contrast agents
Supply of additional iodine based contrast agents to NHS Scotland and the Health and Social Care Trusts in Northern Ireland.
Lot 8 - a single supplier framework agreement awarded on a line by line basis.
Procedure terms & legal framework
From the official record · publisher note attached- Procedure method
- Award procedure without prior publication of a call for competition
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Goods
- Notice status
- Awarded without competition
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Framework agreement
- Who may use this agreement
- Not stated in the notice; call-off rights may be limited to the establishing authority
- Competition type
- Direct award (no call for competition)
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- Unspecified in notice
- First published
- 9 Jun 2023, 10:24 BST
- Last source update
- 9 Jun 2023, 10:24 BST
- FTS notice number
2023/S 000-016382- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-03d4f4Find a Tender
- Why no open competition
- The procurement falls outside the scope of application of the directive
- Published justification
This VEAT Notice is to advise the need for modification to meet the additional demands of the Scottish Health and Social Care sector during the Covid-19 pandemic and associated recovery, to maintain supply and remove unnecessary disruption from the Authority due to circumstances unforeseen by the Authority in line with Regulation 72(1)(c) of the Public Contracts (Scotland) Regulations 2015.
- Review procedure
Economic operators should approach the contracting authority in the first instance. However, the only formal remedy is to apply to the courts:
An economic operator that suffers, or is at risk of suffering, loss, or damage attributable to a breach of duty under the Public Contracts (Scotland) Regulations 2015 or the Procurement Reform (Scotland) Act 2014, may bring proceedings in the Sheriff Court or the Court of Session.
The bringing of court proceedings against the Authority after the Framework Agreement has been entered into will not affect the Framework Agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise, the remedies that may be awarded by the courts where the Framework Agreement has been entered into are limited to the award of damages.
Publisher note: The estimated value(s) referred to in Section II.I.7 and eight (8) Lots covers the twelve (12) month modification period of the framework agreement. (SC Ref:732358)
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast8 suppliers are admitted to this framework without individual award values or dates, see the supplier list below.
Contracts
Barium Based Contrast Agents
- Signed
- 17 May 2023
- Value
- £38,123
- Status
- active
Ultrasound Contrast Agents
- Signed
- 17 May 2023
- Value
- £87,568
- Status
- active
Macrocyclic Gadolinium Based Contrast Agents
- Signed
- 17 May 2023
- Value
- £708,314
- Status
- active
Linear Gadolinium Based Contrast Agents
- Signed
- 17 May 2023
- Value
- £323,626
- Status
- active
Non-ionic monomeric iodine-based contrast agents
- Signed
- 17 May 2023
- Value
- £5,620,660
- Status
- active
Non-ionic dimeric Iodine based contrast agents
- Signed
- 17 May 2023
- Value
- £148,408
- Status
- active
Non-ionic monomer Iomeprol contrast agent
- Signed
- 17 May 2023
- Value
- £54,522
- Status
- active
Additional Iodine based contrast agents
- Signed
- 17 May 2023
- Value
- £355,673
- Status
- active
Contracting authority & participating public bodies
Dispute resolution & review bodies
- Sheriff Court HouseReview body
Framework contractors & participating bidders
6 commercial parties on the notice- Bayer PlcFramework contractor
- Bracco UK LtdFramework contractor
- Bracco UK LtdFramework contractor
- GE HealthcareFramework contractor
- Guerbet Laboratories LtdFramework contractor
- LameproFramework contractor
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.